Showing 7611-7620 of 10623 results for "".
- Unveiling the Role of Granzyme K in Chronic Inflammatory Diseaseshttps://reachmd.com/news/unveiling-the-role-of-granzyme-k-in-chronic-inflammatory-diseases/2471106/Quick Summary Granzyme K, a protein largely expressed by CD8+ T cells, has been identified as a key driver in activating the complement system, leading to inflammation and tissue damage in autoimmune diseases. This discovery offers new therapeutic possibilities for
- Unveiling the Molecular Basis of Eosinophilic Esophagitishttps://reachmd.com/news/unveiling-the-molecular-basis-of-eosinophilic-esophagitis/2471090/What's New A recent study led by Children's Hospital of Philadelphia offers groundbreaking insights into the molecular interactions that underlie eosinophilic esophagitis, a persistent food allergy affecting many children. The study has identified a specific
- GW Earns Skin Smart Campus Recognitionhttps://reachmd.com/news/GW-Earns-Skin-Smart-Campus-Recognition/2471093/The National Council on Skin Cancer Prevention recognized George Washington University as a Skin Smart Campus for its ongoing commitment to fostering a safe and healthy learning environment, with a focus on skin cancer prevention and UV safety, the university announced. The Skin Smart Camp
- Baricitinib: A New Hope for Lichen Planus Reliefhttps://reachmd.com/news/baricitinib-a-new-hope-for-lichen-planus-relief/2471067/Quick Summary Researchers from the Mayo Clinic have identified baricitinib as a promising treatment for lichen planus, leading to significant improvements. The trial showed an 83% improvement in symptom responsiveness within 16 weeks. Understanding Lichen Pl
- Study Shows Teledermatology Gaining Traction, While Challenges Remainhttps://reachmd.com/news/study-shows-teledermatology-gaining-traction-with-challenges/2471061/Newly published research explored patient perceptions and satisfaction with teledermatology services in the post-pandemic era, showing high satisfaction rates and preferences for hybrid care models. The study surveyed a diverse group of dermatology patients who had utilized teledermatology
- Ethics Checklist Published for Portable MRI Researchhttps://reachmd.com/news/ethics-checklist-published-for-portable-mri-research/2471075/What's New The University of Minnesota announces the publication of the first ethics checklist tailored for portable MRI brain research, a tool intended to address pressing ethical, legal, and societal issues as research expands into communities. Significanc
- Unveiling Genetic Mysteries: WES Finds Ultra-Rare Variants in JMEhttps://reachmd.com/news/unveiling-genetic-mysteries-wes-finds-ultra-rare-variants-in-jme/2471054/What's New The study identifies ultra-rare genetic variants associated with JME using whole exome sequencing, revealing potential genetic pathways contributing to the disorder. Significance Understanding these genetic variants could lead to improved
- Advancements in Diagnosing Visual Deficits in Mild Traumatic Brain Injuryhttps://reachmd.com/news/advancements-in-diagnosing-visual-deficits-in-mild-traumatic-brain-injury/2471053/What's New A study led by Rasdall and colleagues introduces a battery of assessments and machine learning methods to better diagnose visual deficits in mild traumatic brain injury patients. Significance This development is significant as it proposes
- New Insights into Senescence in Melanoma and Cancer Therapyhttps://reachmd.com/news/new-insights-into-senescence-in-melanoma-and-cancer-therapy/2471035/What's New A recent study led by the University of Barcelona uncovers a molecular mechanism that could redefine strategies to eliminate senescent cells in cancer patients post-treatment. Significance Understanding this mechanism is significant as it
- Underreported Gout Flares: A Call for Better Patient Managementhttps://reachmd.com/news/underreported-gout-flares-a-call-for-better-patient-management/2470974/Quick Summary A study led by Dr. Jasvinder A. Singh and published in ACR Open Rheumatology explores the issue of underreported gout flares in the U.S. The research found that only 28% of gout flares were reported to healthcare providers, highlighting a substantial c